Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Bullboard Posts
Comment by davikingon Aug 08, 2019 8:40am
107 Views
Post# 30005878

RE:News Corporate Updaate

RE:News Corporate UpdaateThe update is not what MM aka Inspector aka STT would be looking for but it is an update., nontheless.
I am not sure how it takes so long to get approval for a much needed trial (redtape). They are using the same hosptials (who are excited) and they say, :"he Company anticipates some sites opening for enrolment beginning in Q3" (aren't we in quarter 3-lets hope it's not Q4. I'd have to look back but I thought the sites were to be opened in Q2.
Ah, the long wait becomes longer.
Bullboard Posts